Hydroxyurea use in prevention of stroke recurrence in children with sickle cell disease in a developing country: A cost effectiveness analysis
Publisher： John Wiley & Sons Inc
E-ISSN： 1545-5017|62|10|1862-1864
ISSN： 1545-5009
Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.10, 2015-10, pp. : 1862-1864
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
